publication date: Dec. 22, 2010

In this issue: 

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation;

Zerhouni Starts Work As NIH Director;

ASCO Honors Eight With Special Awards;

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer;

ASCO Strategic Plan Seeks To Increase Value to Members, Public;

Funding Opportunities.

Download (PDF 376KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.